Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Clarification On Article Published In Business Standard On July 20, 2022

 This has reference to the article published in Business Standard on July 20, 2022 with title "Torrent Pharma expected to enter diagnostics space in next 2-3 months". We would like to clarify that Torrent Pharma has not made investments into Torrent Diagnostics Private Limited. This is a Company formed under Torrent Investment Private Limited as part of the group''s diversification strategy.
21-07-2022

Torrent Pharma expected to enter diagnostics space in next 2-3 months

 A company called Torrent Diagnostics Private Ltd was incorporated in February this year and has a Torrent Pharmaceuticals executive director as one of its directors.
20-07-2022
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Statement Of Investor Complaints For The Quarter Ended June 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Mahesh AgrawalDesignation :- Company Secretary and Compliance Officer
14-07-2022
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Allotment

 In furtherance to our letter dated 25-May-22, we would like to inform that the Company has allotted 16,92,22,720 Bonus equity shares of Rs. 5/- each on Wednesday, 13-Jul-22. The shares are allotted in the ratio 1: 1 i.e. 1 (One) new fully paid-up equity share of Rs. 5/- each for every 1 (One) fully paid-up equity share of Rs. 5/- each held by the members whose name appears in the Register of Members or in records of National Securities Depositories Limited or Central Depositories Services (India) Limited as the beneficial owners as on 11-Jul-22, the Record Date fixed for this purpose.
13-07-2022
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2022 ,inter alia, to consider and approve We would like to inform you that a meeting of the Board of Directors will be held on Friday, 29-Jul-22, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on 30-Jun-22.
11-07-2022

Torrent Pharma shares in focus as stock trades ex-bonus

 Torrent Pharma's board recommended the issue of bonus shares in the ratio of 1:1
08-07-2022

Torrent Pharma's bonus shares to be issued next week: Are you eligible?

 Torrent Pharma has announced bonus share in the ratio of 1:1
06-07-2022
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed herewith the copies of Newspaper cuttings published in Financial Express (English & Gujarati) on 5th July, 2022 in connection with the 49th Annual General Meeting and E-Voting Procedure.
05-07-2022
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Reg. 34 (1) Annual Report.

 Please find attached herewith soft copy of the Integrated Annual Report 2021-22 (comprising of Notice calling 49th Annual General Meeting (AGM) along with Audited Financial Statements, Directors'' Report, Auditors' Report, etc.) of Torrent Pharmaceuticals Limited ("the Company") in compliance with Regulation 34(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations').
04-07-2022

This large cap pharma stock corrected 17% from 52-week-low ahead of bonus issue

 A large cap firm with a market valuation of 49,361 crore that is involved in the pharmaceutical industry is Torrent Pharmaceuticals Ltd.
02-07-2022
Next Page
Close

Let's Open Free Demat Account